v3.10.0.1
Other (Income)/Deductions - Net - Footnotes - Collaborative Arrangements (Details) - USD ($)
$ in Millions
3 Months Ended 12 Months Ended
Sep. 30, 2018
Apr. 01, 2018
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Apr. 30, 2018
Licensing Agreements [Member]            
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]            
Proceeds received from upfront payments and milestone payments     $ 118      
Proceeds from licensing arrangement       $ 101 $ 33  
Shire [Member] | Licensing Agreements [Member]            
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]            
Proceeds from licensing arrangement $ 35 $ 75 110      
Merck [Member] | Collaborative Arrangement [Member]            
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]            
Proceeds received from upfront payments and milestone payments     40 150    
Phase 2b Ready AMPA Receptor Potentiator For CIAS [Member] | Disposed of by Sale, Not Discontinued Operations [Member]            
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]            
Cash received for disposition     85     $ 75
Distribution Rights [Member]            
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]            
Gain related to sale of intangible assets     $ 62 $ 85 $ 50